INTRODUCTION
Coronavirus virions are enveloped particles containing three or four structural proteins: spike (S) protein, membrane (M) protein, nucleocapsid (N) protein, and hemagglutinin-esterase (HE) protein (Lai, 1990) . The S protein is a glycoprotein of 180 kDa, which often is cleaved by host proteases into two 90-kDa subunits (Yoshikura and Tejima, 1981; Sturman et a/., 1985) . This protein, which is the outermost protein on the viral envelope, interacts with the host cell receptor, causes cell-cell fusion, and elicits neutralizing antibodies (Collins et a/., 1982; Sturman and Holmes, 1983; Sturman et al., 1985) . The M protein is a transmembrane glycoprotein of 23 kDa, which appears to interact with the nucleocapsid inside the virus particle (Sturman et a/., 1980) . The N protein is a phosphoprotein of 50-60 kDa in size, which interacts with viral RNA (Stohlman et al., 1988 65 kDa, which projects from the viral envelope (King et a/., 1985; Yokomori eta/., 1989) . While the S, M, and N are present in all coronaviruses, the HE protein is detected only in some species of coronavirus, such as bovine coronavirus (BCV) (King et al., 1985; Vlasak et a/., 1988a; Parker et al., 1989 ) turkey coronavirus (TCV) (Dea and Tijssen, 1988) , and human coronavirus (OC43) (Hogue et al., 1984; Hogue and Brian, 1986) but not in avian infectious bronchitis virus (IBV) or porcine transmissible gastroenteritis virus (TGEV) (Garwes and Reynolds, 1981; Stern and Sefton, 1982) . Mouse hepatitis virus (MHV) is the prototypic member of the Coronaviridae, which contains a nonsegmented, positive-sensed genomic RNA of 3 1 kb in length (Pachuk et a/., 1989; Lee et a/., 1991). In infected cells, seven or eight virus-specific mRNA species are detected. The mRNAs are characterized by a nested-set structure with common 3'-terminal sequences but with unique 5'-regions (Lai et a/., 1981; Leibowitz et al,, 1981) . Although structurally polycistronic, each mRNA encodes only one protein, which is translated from the unique 5'-region. For instance, the S protein is translated from mRNA 3, M protein from mRNA 6, and N protein from mRNA 7 (Leibowitz et a/., 1982; Siddell, 1983) . In addition, the mRNAs possess a common leader sequence of approximately 72 nucleotides in length, which is derived from the 5'-end of the viral genome (Spaan et al., 1983; Lai et al., 1984) . The 3'-end of the leader RNA contains a pentanucleotide sequence of UCUAA, which is homologous to the intergenic sequences present at the beginning of each gene. The copy number of this pentanucleotide sequence was two to four, depending on the particular virus strain (Makino eta/., 1988) and varied after serial passage of virus in cell culture (Makino and Lai, 1989a) . For example, in the neurotropic JHM strain of MHV, the wild-type virus contained three copies of UCUAA; but after 10 to 12 passages, the number of copies was reduced to two (Makino and Lai, 1989a) . This change was accompanied by an alteration in the pattern of mRNA expression (Makino and Lai, 1989a) . Specifically, the JHM variant with two copies of UCUAA (designated as JHM (2)) made a large amount of mRNA 2-1, while wild-type JHM with three copies (JHM(3)) made only a small amount (Makino and Lai, 1989a; Shieh et a/., 1989) . In vitro translation studies revealed that HE protein was encoded by mRNA 2-l (Shieh ef a/., 1989). Thus, HE protein expression in JHM was controlled by the copy number of UCUAA in the leader (Makino and Lai, 1989a; Shieh et al., 1989) .
The HE protein possesses an esterase activity similar to the receptor-destroying enzyme (RDE) of influenza C virus (Vlasak et al., 1988b) , and also a hemagglutinin activity (Vlasak et a/., 1988b; Parker et a/., 1989) . However, the hemagglutinin activity in JHM is very weak (Yokomori et a/., 1989) . In order to better understand the biological significance of the HE protein, we examined the structure and expression of HE in several different strains of MHV. The results demonstrated that HE expression varied at both transcriptional and translational levels amongst MHV strains. In contrast to the conserved expression of the other three structural proteins, S, M, and N, the HE gene in most MHV strains appears to be a pseudogene. The significance of the maintenance of HE expression in some of the MHV strains will be discussed.
MATERIALS AND METHODS

Viruses and cell culture
The MHV strains used in this study were from several different sources. Plaque-cloned JHM(2) and JHM(3) viruses (Makino and Lai, 1989a; Shieh et al., 1989; Yokomori et a/., 1989) which have two and three copies of UCUAA in the leader sequence, respectively, and strain A59 were the same as those reported in a previous study (Yokomori et al., 1989) . The two variants of JHM-DL (a large-plaque variant of JHM (Weiner, 1973; Stohlman et a/., 1982) ) containing two or three copies of UCUAA were obtained by a modification of the published procedures (Makino and Lai, 1989a) . Briefly, JHM-DL was passaged serially without dilution in DBT cells, a murine astrocytoma cell line (Hirano et al., 1974) . Virus harvested at the end of the fifth passage was passaged one additional time in DBT cells at low multiplicity of infection (m.o.i.) to eliminate possible DI particles. Virus variants were plaque-purified, and the number of UCUAA copies at the 3'-end of the leader was determined by primer extension (Makino et al., 1988) . Viruses with either two or three copies of UCUAA in the leader were designated JHM-DL(2) and JHM-DL(3), respectively. MHV-1 and MHV-S were obtained from Dr. Paul Masters of Wadsworth Center for Laboratories and Research, New York State Depar-tment of Health. MHV-2 has been described previously (Lai and Stohlman, 1981) . Two isolates of MHV-3, i.e., MHV-3-L and MHV-3-Yac, were plaque-purified from stocks originally obtained from Dr. Lucie Lamontagne of the University of Montreal. Viruses were propagated in DBT cells as described previously (Makino et a/,, 1984b) . DBT cells also were used for all the in vivo metabolic labeling experiments.
35S-labeling of intracellular proteins and preparation of cell lysates
Intracellular proteins of virus-infected DBT cells were labeled, and cell lysates made as described previously (Yokomori et a/., 1989) . Briefly, when the cytopathic effect (CPE) in MHV-infected DBT cells reached 95%, cells were starved in methionine-free media for 30 min, and then [35S]methionine (1 193 Ci/mmol; ICN Translabel) was added to a final concentration of 50 &i/ml. Cells were pulse-labeled for 20 min and then immediately placed on ice, washed with ice-cold phosphatebuffered saline (PBS), and lysed with lysis buffer (1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS in PBS) containing 1 mM phenylmethylsulfonyl fluoride (PMSF; Sigma). Cell lysates were passed through a 19-gauge syringe needle five times, transferred to Eppendorf tubes, and spun at 12,OOOgfor 10 min at 4". Supernatant were harvested and stored at -70" until required. lmmunoprecipitation and SDS-PAGE lmmunoprecipitation was performed as previously described (Yokomori eta/., 1989) using rabbit hyperimmune serum prepared against purified JHM(2) virus (Yokomori et a/., 1989) . After immunoprecipitation, samples were denatured in 2X sample buffer (0.06 M Tris-HCI, 2% SDS, 25% glycerol, 5% 2-mercaptoethanal, and 0.1% bromphenol blue) at 37" for 20 to 30 min, and centrifuged at 12,000g for 5 min. The supernatants were electrophoresed on 7.5 to 15% gradient or 12.5% straight polyacrylamide gels containing 0.1% SDS.
32P-labeling of intracellular RNA of virus-infected cells
DBT cells were infected with various strains of MHV at an m.o.i. of 1-5. Virus-infected cells were labeled with 200 &i/ml of [32P]or-thophosphate (ICN Biochemicals) from 5.5 to 8 hr postinfection in the presence of actinomycin D (2.5 pglml, Sigma). RNA extraction was performed as described below.
Preparation of virion RNA and intracellular RNA Virion RNA was purified by a modification of the procedure described by Makino et al. (1984a) . DBT cells were infected at an m.o.i. of 1-5. Culture supernatant was harvested at 15-20 hr postinfection, and cell debris removed by centrifugation at 1500 rpm for 5 min. Virus was then precipitated by the addition of ammonium sulfate to 50% saturation, and purified by ultracentrifugation twice in discontinuous sucrose gradients (Banner er a/., 1990) . The virus pellet was incubated at 37" for 1 hr in a solution containing 100 pg/ml of proteinase K, 100 mM Tris-HCI (pH 7.5), 12.5 mM EDTA, 150 mM NaCI, and 1% SDS, extracted twice with phenol/chloroform (l/l) and the RNA precipitated with ethanol. Virion RNA isolated was used for RNA sequencing and primer extension. Intracellular RNA was isolated essentially as described by Makino et a/. (1984b) . Briefly, infected cells were lysed at 9 hr postinfection with NTE buffer (0.1 M NaCI, 0.01 M Tris-HCI, pH 7.2, and 1 mM EDTA) containing 0.5% Nonidet P-40, and the nuclei were removed by brief centrifugation. Supernatants were treated with proteinase K and the RNA extracted as described above for virion RNA.
cDNA cloning of viral mRNAs by polymerase chain reaction (PCR) cDNA clones corresponding to the 5'-unique coding region of mRNA 2-1 were produced using PCR as described previously (Makino et al,, 1988 ). Intracellular RNA from virus-infected cells was annealed with primer 226 (5'-CTAACACCGCTATCCGTCAT-3') which is complementary to the 3'-conserved region of gene 2-1, and cDNA was synthesized with reverse transcriptase (Boehringer Mannheim Biochemicals). For PCR amplification of the cDNA, a second primer, 78 (5'-AGCTTTACGTACCCTCTCTACTCTAA- which is homologous to the 5'-end of the leader plus 7 additional nucleotides containing the SnaBl restriction site, was added (Makino and Lai, 1989b) . The mixture was incubated for 25 cycles of 94" for 30 set, 54" for 90 set, and 72" for 3 min. PCR products representing the 5'-region of mRNA 2 (2.1 kb, consisting of 0.8 kb from gene 2 and 1.3 kb from HE gene) and 2-l (1.3 kb) were excised from low melting agarose (Sea Plaque, FMC Bioproducts, Rockland, ME) and extracted with phenol and chloroform. The cDNA was phosphorylated and blunt-ended with polynucleotide kinase and T4 DNA polymerase (Boehringer Mannheim Biochemical@, and ligated into the Smal site of the vector pTZ18U (United States Biochemical Corp).
RNA and DNA sequencing RNA sequencing of purified virion genomic RNA was performed using modification of the dideoxyribonucleotide chain-termination method @anger eta/., 1977) as described previously (Banner eta/., 1990) . Primer 56 (5'-CGCCGAATGGACACGTC-3'), which iscomplementary to nucleotides 172 to 188 from the 5'-end of genomic RNA (Makino and Lai, 198913) was used to obtain the sequence of the leader RNA, including the UCUAA repeat region. For the HE gene sequence, DNA sequencing was carried out by dideoxyribonucleotide chain-termination method (Sanger et al., 1977) , using primers corresponding to different regions of the gene. Some regions also were confirmed by RNA sequencing with the same primers and the method described above.
ln vitro transcription and translation
Recombinant plasmid pTZl8U(HE), derived from PCR products of various strains of MHV, were constructed such that the T7 RNA polymerase promoter preceded the leader sequence and translation initiation site of the HE gene. Plasmids were linearized by digestion with &al and transcribed in vitro with T7 RNA polymerase as described previously (Makino and Lai, 1989b) . The RNA transcripts were translated in a mRNA-dependent rabbit reticulocyte lysate or wheat germ extract (Promega Biotec) in the presence of [35S]methionine (NEN Du Pont), with or without canine pancreatic microsomal membrane (Promega Biotec). Reactions were carried out as recommended by the manufacturer.
RESULTS
Detection of intracellular virus-specific HE protein from various strains of MHV
To examine the HE expression of different MHV strains, virus-infected cells were labeled with [35S]methionine, and the virus-specific proteins were im-BANNER, AND LAI Virus-infected cells were radiolabeled with [35S]methionine for 20 min at 8 to 10 hr postinfection.
Cell lysates were immunoprecipitated with anti-JHM(2) rabbit serum (Yokomori er al., 1989) , and analyzed by electrophoresis on 7.5 to 15% gradient polyacrylamide gels. The arrows indicate viral structural proteins. Lanes S, 1, 2, and 3 represent MHV-S, MHV-1, MHV-2, and MHV-3, respectively. munoprecipitated with polyclonal antibodies directed against JHM(2) virions. Figure 1 shows that while large amounts of HE protein could be detected in cells infected with MHV-S, JHM(2), and JHM-DL(2), only small amounts were detected in JHM(3)-and JHM-DL(3)-infected cells. This finding is consistent with our previous studies, which showed that JHM viruses with three copies of UCUAA in the leader RNA synthesized a much lower amount of HE protein than the virus with two UCUAA copies (Shieh et al., 1989; Yokomori eta/., 1989) . Since the JHM and JHM-DL variants with different copy numbers of UCUAA were isolated independently from different virus stocks, these findings further suggest that variations in the amount of HE protein are related to the copy number of UCUAA rather than some other mutation(s). Strains A59, MHV-1, MHV-2, and two different plaque isolates of MHV-3 did not synthesize HE or any other additional proteins which could be recognized by anti-JHM(2) polyclonal antibodies. These results showed that many strains of MHV do not express HE protein. In contrast to HE, the other three structural proteins (S, N, and M) were synthesized consistently by all viruses. mRNA 2-1 expression by different strains of MHV To determine whether the lack of synthesis of HE protein by different MHV strains was at the transcriptional or translational level, 3'P-labeled virus-specific mRNA from virus-infected cells was examined by aga-rose gel electrophoresis after glyoxal denaturation. Figure 2 shows the intracellular mRNA patterns of the various strains of MHV. Surprisingly, mRNA 2-1, which encodes HE protein, was synthesized by most of the viruses, including MHV-2, and two isolates of MHV-3, even though these strains failed to synthesize any HErelated protein (Fig. 1) . Thus, the mRNA 2-l of MHV-2 and MHV-3 was nonfunctional, or defective in translational control. Consistent with their failure to express HE protein, mRNA 2-l was not detected in A59 or M HV-1 -infected cells.
Previously we have shown that JHM(3) synthesizes less mRNA 2-1 than JHM(2) (Makino and Lai, 1989a, Shieh et a/., 1989) . In this study, we confirmed this observation ( Fig. 2) and extended it to include the large plaque variant of JHM, JHM-DL. Specifically, substantially more mRNA 2-l was detected in cells infected with JHM-DL(2), which contains two copies of UCUAA, than JHM-DL (3), which contains three copies of UCUAA (Fig. 2) . The amounts of HE protein synthesized by these viruses (Fig. 1 ) correlated well with the amounts of mRNA 2-l synthesized. Figure 2 also revealed that MHV-1, which failed to synthesize any detectable mRNA 2-1, synthesized a novel mRNA species, which was smaller than mRNA '; lanes from the same gel were exposed for various times to adjust the intensity of the bands. Lane designations are the same as in Fig. 1 . Virus-specific mRNA species are indicated by numbers, and mRNA 2-l IS indicated by small arrowheads. The novel mRNA between mRNA 2 and mRNA 3 in MHV-1 is indicated by the larger arrowhead.
2-l but larger than mRNA 3. Since no HE-related protein was detected in MHV-l-infected cells (Fig. l) , this mRNA also appeared to be nonfunctional.
Sequence analysis of HE gene
We wanted to understand the molecular basis of the variable HE gene expression in different MHV strains and also the discrepancy between the expression of mRNA 2-1 and synthesis of HE protein by some viruses. Therefore, the sequences of the HE gene region of different viruses were obtained by either direct RNA sequencing or DNA sequencing of PCR products. Oligonucleotides corresponding to the leader RNA and a conserved 3'-end region of the HE gene were used as primers for PCR. Due to the nested-set structure of the coronavirus mRNAs, these clones included sequences from the coding region of the HE gene, the leader-fusion site of mRNA 2-1, and its genomic intergenic sequences. Thus, the 5'unique coding regions of both mRNA 2 and mRNA 2-l were obtained. Sequence data from the HE genes of these viruses revealed substantial numbers of base substitutions, deletions, and insertions spread throughout the coding region of gene 2-l in most viruses. As a result, the open reading frame (ORF) for the HE protein was truncated in A59, MHV-1, MHV-2, and both isolates of MHV-3 ( Fig. 3) . Specifically, in contrast to the HE genes of JHM and MHV-S, which had a coding capacity of 440 amino acids, that of A59 encoded only 14 amino acids, MHV-2, 97 amino acids, MHV-3-Y, 27 amino acids, while that of MHV-3-L was 135 amino acids. Although MHV-1 did not synthesize mRNA 2-1, its ORF was capable of encoding a protein of 268 amino acids. The usual initiating AUG of the HE gene in several viruses was also mutated or deleted (Fig. 3 ) thus providing the potential for additional HE gene variation in different MHV strains.
To confirm the sizes of the ORF predicted from the RNA sequence data, the HE genes of some of the viruses were examined by in vitro translation. Capped RNAs were transcribed in vitro from cDNA clones using T7 RNA polymerase, and then used for in vitro translation in either wheat germ extract or rabbit reticulocyte lysate system. The sizes of the 35S-labeled translation products agreed with the predicted ORF (Fig. 4A) : The MHV-3-L clone yielded a 14-kDa translation product, whereas the MHV-3-Y clone yielded an 4-kDa product. Furthermore, in the presence of canine pancreatic microsomal membrane, MHV-3-L RNA yielded two additional protein products (Fig. 4~3) . The higher band possibly represented glycosylated product, since the ORF contained one potential N-linked glycosylation site. The middle band was of the same size as the primary translation product in the absence of membrane and thus represented the native product of 14 kDa. The lower band most likely represented the core protein, from which the signal peptide had been cleaved off. These results suggest that this truncated HE protein was properly translocated and processed in vitro. However, these protein products were not detected in infected cells (Fig. 1) .
The UCUAA copy number in the leader and intergenic sequence of the HE gene From studies with JHM(2) and JHM(3), it was concluded that the transcription of mRNA 2-l depends on the interaction between the repeated UCUAA sequence motif in the leader RNA and the intergenic sequences upstream of the HE gene (Makino and Lai, 1989a; Shieh et a/., 1989) . Similar conclusions were reached with JHM-DL(2) and JHM-DL(3).
Sequence analysis of the intergenic regions of the HE gene and the leader RNA was further extended to all of the other viruses. Table 1 summarizes the intergenie sequences preceding the HE gene. All viruses examined contained a stretch of UA-rich sequence similar to that of JHM. The only exception was A59, which had an A to G substitution, and correspondingly, did not synthesize mRNA 2-1, despite the fact that it contained two copies of UCUAA in the leader RNA (Makino and Lai, 1989a; Shieh et a/., 1989) . The intergenic sequence preceding the HE gene was slightly different from the consensus transcription initiation motif seen in most of the other MHV genes, i.e., gene 3 and gene 7 (Table 1) . This finding may explain why gene 2-1 was regulated by the number of UCUAA copies in the leader RNA, while the other genes were constitutively expressed. Since MHV-1 had an identical intergenic sequence preceding the HE gene (Table l) , the failure of this virus to transcribe mRNA 2-l must have been due to the presence of three copies of UCUAA at the 3'-end of leader sequence, or some other as yet undetermined reason.
The number of copies of UCUAA in the leader RNA of the various MHV strains was determined by primer extension and direct RNA sequencing of genomic RNA. The results showed that MHV-S, MHV-2, MHV-3-L, and MHV-3-Y had two copies while MHV-1 had three ( Fig. 5 and data not shown) . As MHV-S, MHV-2 and both MHV-3 isolates transcribed mRNA 2-1, while MHV-1 did not (Fig. 2) these results further supported the correlation between the UCUAA copy number and expression of the HE gene. In each case, those viruses with three repeats did not transcribe mRNA 2-l efficiently.
As described above, MHV-1 did not synthesize mRNA 2-1, but instead, made a novel mRNA smaller BANNER, , 1988; Shieh et al., 1989) ..c ....................................................................................  MHV-S  ....................................................  .G......................... than mRNA 2-1 and larger than mRNA 3 (Fig. 2) . By performing PCR with a pair of oligonucleotides, one identical with the 5'-end of the leader RNA and the other complementary to the 3'-end region of the HE gene, the initiation site of this novel mRNA was determined and compared with the corresponding genomic sequence (Fig. 6) . As a result of mutations and a deletion in this region, the genomic sequence from nucleotides 794 to 804 (ATCCGGGTCTT) was converted to ATTTAA-TCTT, which resembled the consensus transcription initiation signal. Comparison of the genomic sequence with the sequence of the novel mRNA indi-cated that this was indeed the transcriptional initiation point for the mRNA species (Fig. 6) . Thus, the specific expression of the novel mRNA in MHV-1 was most likely caused by the interaction of the three copies of UCUAA in the leader with the newly acquired intergenie site in the middle of the HE gene.
DISCUSSION
The results presented in this paper show that the functional integrity of the HE gene is not well maintained in murine coronaviruses. Of the MHV strains BANNER, examined, only two viruses (JHM and MHV-S) made an intact HE protein. Other viruses had a defective gene or were defective in transcription such that no HE protein was synthesized. The failure to synthesize an HE protein was due to several different reasons in different MHV strains: (1) The mRNA for the HE protein (mRNA 2-1) was not synthesized because the number of copies of the UCUAA pentanucleotide in the leader sequence was not optimum for transcription (e.g., JHM(3) and MHV-1, which contain three UCUAA copies), or the consensus intergenic sequence (e.g., A59) was mutated.
(2) The mRNA was synthesized but due to sequence alterations resulting from mutations, deletions or insertions, the usual initiation codon of the HE ORF was lost, or the reading frame closed prematurely (e.g., A59, MHV-2, and MHV-3-Land MHV-3-Y). These findings are in striking contrast to the other three MHV structural protein genes, S, M, and N, which, despite some degree of sequence diversity, are consistently expressed and the ORFs are well-maintained.
These results suggest that there is no selection pressure to preserve the complete HE ORF, and consequently, this gene has drifted into a pseudogene.
Furthermore, Also, the JHM virus with an expressed HE protein was naturally selected during JHM passages in tissue culture (Makino and Lai, 1989a) . Thus, the presence of HE protein may have provided selective advantages under certain conditions. Interestingly, cold-sensitive mutants isolated from a persistent MHV-S infection of Kirsten murine sarcoma virus-transformed BALB/C cells failed to make HE protein (Yoshikura and Tejima, 1981) . Also, Morris eta/. (1989) have isolated JHM variants from Wistar Furth rats with a JHM-induced demyelinating disease. Besides a change in the S protein, these variants had a large deletion in the HE gene, resulting in the loss of HE protein expression (La Monica et al., 199 1). These data further suggest that under certain conditions, the HE protein may provide some selection advantage.
The HE protein also is present in some other coronaviruses which have a hemagglutinin activity including BCV and human coronavirus OC43, (Vlasak et a/., 1988b) . The HE protein of BCV also exhibits an acetylesterase activity similar to the receptor destroying activity of influenza C virus (Vlasak et a/., 198813) . A similar activity has been demonstrated for the HE protein of MHV (Yokomori et al,, 1989) . Data have been obtained which suggest that the HE protein is required for BCV infectivity. HE protein was the target of neutralizing monoclonal antibodies, which also inhibited hemagglutinin and esterase activities (Deregt and Babiuk, 1987; Parker eta/., 1990) . In addition, treatment with diisopropyl fluorophosphate (DFP), an inhibitor of esterase, was found to inhibit virus replication (Vlasak et al., 1988a) . Similar requirements have not been demonstrated for MHV. It should be noted, however, that the presence of the HE protein does alter some biological properties of the virus. For example, in cultured cells, JHM(2) became dominant over JHM(3) after serial undiluted passages (Makino and Lai, 1989a) . In mice, JHM(2) showed greater virulence and neurotropism than JHM(3) (Yokomori, unpublished data) . Finally, passive immunization with monoclonal antibodies against HE protein protected mice from JHM(2) infection (Yokomori, unpublished data). These data suggested that HE may play a role in neuronal infection. Although MHV-3 isolates examined retained a truncated HE ORF, and a protein product could be synthesized and properly processed in an in vitro translation system, no HE-related proteins could be detected in infected cells. The failure to detect these truncated HE proteins in viva was not readily apparent. Perhaps the predicted initiating AUG was not in an ideal context in infected cells, although the sequence around this AUG agrees with the optimum translation context described by Kozak (1987) . Also, the truncated protein products may degrade rapidly; however, even short pulse-labeling (15 min) did not reveal any products (Fig. 1) . Additionally, because the truncated ORFs retained the putative esterase domain and signal sequence but lacked the C-terminal membrane-anchoring domain, we have investigated the possibility that the truncated HE protein may have been released into the media. No HEspecific esterase activity was detected in supernatants from infected cells (data not shown). Thus, the reason that no truncated HE protein was detected in these MHV strains remains unclear.
Another interesting characteristic of the HE gene is its transcriptional control by the copy number of UCUAA pentanucleotide sequence in the leader RNA. Both this report and previous publications (Makino and Lai, 1989a; Yokomori et al., 1989) indicate that only JHM variants with two copies of UCUAA in the leader expresses mRNA 2-1 efficiently, whereas JHM variants with three copies of UCUAA transcribe only small amounts of this mRNA (Makino and Lai, 1989; Shieh et al., 1989) . This mechanism of transcriptional control also was confirmed with a variant of JHM, JHM-DL. Furthermore, we found that other MHV strains also utilized the same transcriptional regulation. Strains MHV-S, MHV-2, and MHV-3 had two UCUAA copies and expressed a large amount of mRNA 2-1, whereas MHV-1 possessed three copies and did not express mRNA 2-1, even though it had the same intergenic sequence preceding the gene as other MHVs. In addition, MHV-1 synthesized a smaller mRNA from a novel downstream site which had a sequence similar to the BANNER. AND IAI consensus transcriptional initiation signal (UUlJ/MJ-CUU vs UCUAAUCUA, respectively). These results strongly suggest that MHV RNA transcription results from an interaction between the leader RNA and the intergenic sequence preceding each gene, although the precise mechanism for this transcriptional control is not yet clear. The differential control of HE gene transcription by the leader RNA may further our understariding of the mechanism of MHV transcription. 
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